Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -27.56%7.04K | -2.43%56.9K | 4.93%21.46K | 14.48%11.83K | -5.17%13.9K | -24.57%9.72K | -6.51%58.32K | -21.22%20.45K | -8.20%10.34K | -2.95%14.66K |
| Selling and administrative expenses | 5.02%7.89K | 7.67%45.82K | 9.78%19.52K | 32.92%10.17K | 8.62%8.62K | -18.22%7.52K | -14.93%42.56K | -26.46%17.78K | -11.57%7.65K | -18.00%7.93K |
| -General and administrative expense | 5.02%7.89K | 7.67%45.82K | 9.78%19.52K | 32.92%10.17K | 8.62%8.62K | -18.22%7.52K | -14.93%42.56K | -26.46%17.78K | -11.57%7.65K | -18.00%7.93K |
| Other operating expenses | -138.88%-855 | -29.71%11.08K | -27.35%1.94K | -38.06%1.66K | -21.45%5.28K | -40.39%2.2K | 27.54%15.77K | 50.03%2.67K | 2.99%2.69K | 23.88%6.72K |
| Operating profit | 27.56%-7.04K | 2.43%-56.9K | -4.93%-21.46K | -14.48%-11.83K | 5.17%-13.9K | 24.57%-9.72K | 6.51%-58.32K | 21.22%-20.45K | 8.20%-10.34K | 2.95%-14.66K |
| Net non-operating interest income (expenses) | -11.83%-5.13K | -68.02%-18.85K | -15.13%-4.83K | -80.51%-4.7K | -111.72%-4.73K | -109.97%-4.59K | -108.59%-11.22K | -116.18%-4.2K | -55.19%-2.6K | -71.79%-2.24K |
| Non-operating interest expense | 11.83%5.13K | 68.02%18.85K | 15.13%4.83K | 80.51%4.7K | 111.72%4.73K | 109.97%4.59K | 108.59%11.22K | 116.18%4.2K | 55.19%2.6K | 71.79%2.24K |
| Other net income (expenses) | 10.15%-2.53K | 4.07%-471 | 5.68%-1.08K | 11.80%-523 | 22.28%-457 | 4.35%-2.82K | 35.22%-491 | -45.86%-1.15K | 12.15%-593 | |
| Special income (charges) | --0 | 10.15%-2.53K | 4.07%-471 | 5.68%-1.08K | 11.80%-523 | 22.28%-457 | 4.35%-2.82K | 35.22%-491 | -45.86%-1.15K | 12.15%-593 |
| -Less:Write off | --0 | -10.15%2.53K | -4.07%471 | -5.68%1.08K | -11.80%523 | -22.28%457 | -4.35%2.82K | -35.22%491 | 45.86%1.15K | -12.15%593 |
| Income before tax | 17.55%-12.17K | -8.19%-78.28K | -6.46%-26.76K | -25.04%-17.61K | -9.55%-19.15K | 5.70%-14.76K | -2.33%-72.36K | 12.28%-25.14K | -2.64%-14.08K | -2.38%-17.48K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 17.55%-12.17K | -8.19%-78.28K | -6.46%-26.76K | -25.04%-17.61K | -9.55%-19.15K | 5.70%-14.76K | -2.33%-72.36K | 12.28%-25.14K | -2.64%-14.08K | -2.38%-17.48K |
| Net income continuous operations | 17.55%-12.17K | -8.19%-78.28K | -6.46%-26.76K | -25.04%-17.61K | -9.55%-19.15K | 5.70%-14.76K | -2.33%-72.36K | 12.28%-25.14K | -2.64%-14.08K | -2.38%-17.48K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 17.55%-12.17K | -8.19%-78.28K | -6.46%-26.76K | -25.04%-17.61K | -9.55%-19.15K | 5.70%-14.76K | -2.33%-72.36K | 12.28%-25.14K | -2.64%-14.08K | -2.38%-17.48K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 17.55%-12.17K | -8.19%-78.28K | -6.46%-26.76K | -25.04%-17.61K | -9.55%-19.15K | 5.70%-14.76K | -2.33%-72.36K | 12.28%-25.14K | -2.64%-14.08K | -2.38%-17.48K |
| Diluted earnings per share | 0 | 0.00%-0.01 | 0 | 0 | 0 | 0 | 0.00%-0.01 | 0 | 0 | 0 |
| Basic earnings per share | 0 | 0.00%-0.01 | 0 | 0 | 0 | 0 | 0.00%-0.01 | 0 | 0 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.